Millennium Management’s SpringWorks Therapeutics SWTX Stock Holding History

Millennium Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-250,000	Closed	-$11.7M	–	6456
2025 Q2	$11.7M	Buy	+250,000	New	+$11.1M	0.01%	2093
2025 Q1	–	Sell	-25,100	Closed	-$907K	–	6387
2024 Q4	$907K	Buy	+25,100	New	+$877K	﹤0.01%	4281
2024 Q2	–	Sell	-70,000	Closed	-$3.45M	–	6514
2024 Q1	$3.45M	Buy	+70,000	New	+$3.24M	﹤0.01%	3253
2023 Q3	–	Sell	-10,000	Closed	-$262K	–	6547
2023 Q2	$262K	Buy	+10,000	New	+$263K	﹤0.01%	4977

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's SWTX Position: Q3 2025 in Review

Millennium Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 544,856 shares — an estimated $25.6M sold.

Millennium Management first reported a position in SWTX in Q3 2019 and held it in 20 quarters. The position peaked at $34.7M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Millennium Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Millennium Management sold 544,856 SpringWorks Therapeutics shares in Q3 2025, an estimated $25.6M.
Millennium Management first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 20 quarters.
Millennium Management's SpringWorks Therapeutics position peaked at $34.7M in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.